long term effects of retatrutide – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version drugs such as Ozempic Retatrutide Side Effects: Risks and

49 Phase 3 trials SYNCHRONISE-1 (in people without diabetes) and SYNCHRONISE-2 (in people with diabetes) are ongoing to assess the efficacy and durability of weight loss with 3.6 and 6 mg doses over 76 weeks (clinical trial numbers NCT06066515 and NCT06066528)

GLP-1 receptor agonists are the weight loss injections most commonly associated with dizziness

95% CI, 1.00 to 1.77) exhibited a significantly elevated risk, whereas dulaglutide did not

The results were striking: women taking GLP-1s showed a 72% improvement in natural pregnancy rates (RR: 1.72, 95% CI 1.22-2.43), meaning they were 1.72 times more likely to conceive naturally compared to the control group